3 min read Home Home News Comparing Enzalutamide and Flutamide as First-Line Androgen Therapy for Japanese Men with Castration-Resistant Prostate Cancer: A Clinical Study 10 months ago Mona Al Absi In 2018, the estimated incidence of prostate cancer was high, with Japan accounting for 6% (78,400 people) of the total...